News

Published on 3 Jun 2024 on Investing.com

GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com


Article preview image

Analysts indicated that GSK's potential liability from the litigation could exceed the $2 billion to...

NASDAQ.SNY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware

(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongs...

Bloomberg via Yahoo Finance 3 Jun 2024

GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward By Investing.com

Analysts indicated that GSK's potential liability from the litigation could exceed the $2 billion...

Investing.com 3 Jun 2024

Unveiling 3 Euronext Paris Dividend Stocks With Yields Up To 8.3%

Amidst a backdrop of rising inflation and economic uncertainty across Europe, the French market h...

Simply Wall St. via Yahoo Finance 3 Jun 2024

Growth Stocks to Avoid Like the Plague: 3 Overpriced Picks Primed to Plummet

Growth stocks can be millionaire-makers and the same ideas can be destroyers of wealth. The...

InvestorPlace 1 Jun 2024

FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD

Sanofi SNY and Regeneron REGN announced that the FDA extended the review period for a regulatory ...

Zacks via Yahoo Finance 31 May 2024

Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More

This week, J&J JNJ and Merck MRK announced proposed acquisitions of private biotech companies. Th...

Zacks via Yahoo Finance 31 May 2024

French pharma Sanofi announces stock purchase plan for employees

A syringe prepared for the flu vaccination of a pregnant woman with the vaccine "Vaxigrip Tetra" ...

dpa international via Yahoo Finance 31 May 2024

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

Shares of Insmed INSM more than doubled in market value on Tuesday after reporting positive topli...

Zacks via Yahoo Finance 29 May 2024

J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate

Johnson & Johnson JNJ announced a definitive agreement with Swiss biotech Numab Therapeutics to a...

Zacks via Yahoo Finance 29 May 2024

3 High-Yielding Dividend Stocks On Euronext Paris With Up To 4.2% Yield

In recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%, refl...

Simply Wall St. via Yahoo Finance 29 May 2024